Featured Research

from universities, journals, and other organizations

Street forms of 'synthetic marijuana' products linked to thousands of hospital emergency departments visits each year

Date:
December 4, 2012
Source:
Substance Abuse and Mental Health Administration (SAMHSA)
Summary:
Street forms of synthetic cannabinoids – so-called “synthetic marijuana” – were linked to 11,406 of the 4.9 million drug-related emergency department (ED) visits in 2010, according to a new report.

Street forms of synthetic cannabinoids -- so-called "synthetic marijuana" -- were linked to 11,406 of the 4.9 million drug-related emergency department (ED) visits in 2010, according to a new report by the Substance Abuse and Mental Health Services Administration (SAMHSA).

Related Articles


Commonly known by such street names as "K2" or "Spice," synthetic cannabinoids are substances that are not derived from the marijuana plant but purport to have the same effect as the drug. Though an increasing number of states have passed laws against the sale of synthetic cannabinoids, they have been marketed as a "legal" alternative to marijuana during the past few years. In July 2012, a comprehensive, national ban was enacted against the sale of synthetic cannabinoids under Title XI of the Food and Drug Administration Safety and Innovation Act.

The new report points out that the use of synthetic cannabinoids is tied to a variety of reported symptoms including agitation, nausea, vomiting, tachycardia (rapid heartbeat), elevated blood pressure, tremor, seizures, hallucinations, paranoid behavior and non-responsiveness.

The report found that youths between the ages of 12 to 29 constituted 75 percent of all hospital ED visits involving synthetic cannabinoids, with males accounted for 78 percent of the ED admissions among this age group. The average age for people involved in synthetic cannabinoid-related ED admissions was younger than for marijuana-related ED visits (24 years old versus 30 years old).

"Health care professionals should be alerted to the potential dangers of synthetic cannabinoids, and they should be aware that their patients may be using these substances," said SAMHSA Administrator Pamela S. Hyde. "Parents, teachers, coaches and other concerned adults can make a huge impact by talking to young people, especially older adolescents and young adults, about the potential risks associated with using synthetic marijuana."

"This report confirms that synthetic drugs cause substantial damage to public health and safety in America," said Office of National Drug Control Policy (ONDCP) Director Gil Kerlikowske. "Make no mistake -- the use of synthetic cannabinoids can cause serious, lasting damage, particularly in young people. Parents have a responsibility to learn what these drugs can do and to educate their families about the negative impact they cause."

Several grantees funded under SAMHSA's various programs are working to prevent the use of synthetic marijuana. Many states are providing prevention education to local communities, including webinars and fact sheets for parents on the signs and symptoms of the use of synthetic marijuana. Questions also are being added to school surveys to determine the incidence and prevalence of the use of synthetic marijuana by youth. Grantees funded by the ONDCP's Drug-Free Communities Support Program have provided tremendous insight to local synthetic marijuana issues and are using environmental policies aimed at limiting access to these dangerous substances in local retail stores.

In addition, SAMHSA's Division of Workplace Programs maintains a list of Department of Health and Human Services-certified laboratories that test regulated specimens for "K2" or "Spice."

The report, "Drug-Related Emergency Department Visits Involving Synthetic Cannabinoids," is based on data drawn from SAMHSA's Drug Abuse Warning Network, a public health surveillance system that monitors drug-related morbidity and mortality. The full report can be viewed at: www.samhsa.gov/data/2k12/DAWN105/SR105-synthetic-marijuana.pdf.


Story Source:

The above story is based on materials provided by Substance Abuse and Mental Health Administration (SAMHSA). Note: Materials may be edited for content and length.


Cite This Page:

Substance Abuse and Mental Health Administration (SAMHSA). "Street forms of 'synthetic marijuana' products linked to thousands of hospital emergency departments visits each year." ScienceDaily. ScienceDaily, 4 December 2012. <www.sciencedaily.com/releases/2012/12/121204145349.htm>.
Substance Abuse and Mental Health Administration (SAMHSA). (2012, December 4). Street forms of 'synthetic marijuana' products linked to thousands of hospital emergency departments visits each year. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2012/12/121204145349.htm
Substance Abuse and Mental Health Administration (SAMHSA). "Street forms of 'synthetic marijuana' products linked to thousands of hospital emergency departments visits each year." ScienceDaily. www.sciencedaily.com/releases/2012/12/121204145349.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins